Non Invasive Prenatal Testing
Non Invasive Prenatal Screening / Testing of Fetal Trisomy:
- Analysis of Fetal Cell-Free DNA in Maternal Blood
- 99% Proven Accuracy for detection & Low False Positive Rate : Downs Syndrome, Lymphocytic Leukemia, and Edward’s Syndrome.
- Based on NGS Bioinformatics
Non Invasive Prenatal Testing
Non Invasive Prenatal Screening / Testing of Fetal Trisomy:
- Analysis of Fetal Cell-Free DNA in Maternal Blood
- 99% Proven Accuracy for Detection & Low False Positive Rate: Down Syndrome, Lymphocytic Leukemia, and Edward’s Syndrome.
- Based on NGS Bioinformatics
Cancer Detection Through Analysis of Circulating Tumor DNA
Circulating Tumor DNA is genetic material shed by cancer cells into the bloodstream.
Targeted Next Generation Sequencing can be utilized to analyze the genomic profile of circulating cancerous tumor DNA in blood to compare with a genetic library of known cancerous cells and identify specific genetic mutations that are associated with the development and progression of cancer.
This information can be used to develop targeted therapies and to screen high-risk individuals for early detection and precision tailor-made cancer treatment regimens.
Cancer Detection Through Analysis of Circulating Tumor DNA
Circulating Tumor DNA is genetic material shed by cancer cells into the bloodstream.
Targeted Next Generation Sequencing can be utilized to analyze the genomic profile of circulating cancerous tumor DNA in blood to compare with a genetic library of known cancerous cells and identify specific genetic mutations that are associated with the development and progression of cancer.
This information can be used to develop targeted therapies and to screen high-risk individuals for early detection and precision tailor-made cancer treatment regimens.